Post COVID-19 cholangiopathy - A deep dive.
作者信息
Bethineedi Lakshmi Deepak, Suvvari Tarun Kumar
机构信息
Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
Dr. NTR University of Health Sciences, Andhra Pradesh, India.
出版信息
Dig Liver Dis. 2021 Oct;53(10):1235-1236. doi: 10.1016/j.dld.2021.08.001. Epub 2021 Aug 9.
Abstract
摘要
相似文献
1
Post COVID-19 cholangiopathy - A deep dive.
Dig Liver Dis. 2021 Oct;53(10):1235-1236. doi: 10.1016/j.dld.2021.08.001. Epub 2021 Aug 9.
2
Post-COVID-19 Cholangiopathy: A Novel Entity.
Am J Gastroenterol. 2021 May 1;116(5):1077-1082. doi: 10.14309/ajg.0000000000001154.
3
Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered".
J Hepatol. 2021 Oct;75(4):990-992. doi: 10.1016/j.jhep.2021.06.024. Epub 2021 Jun 24.
4
Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.
Transplant Proc. 2021 May;53(4):1132-1137. doi: 10.1016/j.transproceed.2021.03.007. Epub 2021 Mar 12.
5
Primary biliary cholangitis associated with SARS-CoV-2 infection.
J Hepatol. 2021 May;74(5):1245-1246. doi: 10.1016/j.jhep.2021.02.006. Epub 2021 Feb 19.
6
Care of the postcoronavirus disease 2019 patient.
Curr Opin Pulm Med. 2021 May 1;27(3):199-204. doi: 10.1097/MCP.0000000000000767.
7
Pathogenesis-directed therapy of 2019 novel coronavirus disease.
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
8
We report a patient who presented intrahepatic cholangitis and cholecystitis after SARS-CoV-2 infection.
J Gastroenterol Hepatol. 2021 Aug;36(8):2037. doi: 10.1111/jgh.15537. Epub 2021 Jun 9.
9
Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis.
Rev Esp Enferm Dig. 2021 Feb;113(2):125-135. doi: 10.17235/reed.2020.7397/2020.
10
COVID-19-associated pancreatic dysfunction.
Hong Kong Med J. 2021 Apr;27(2):157-159. doi: 10.12809/hkmj209056. Epub 2021 Apr 9.
引用本文的文献
1
Altered liver hemodynamics in patients with COVID-19: a cross sectional study.
J Ultrasound. 2025 Apr 2. doi: 10.1007/s40477-025-01012-z.
2
Post-COVID-19 cholangiopathy: Systematic review.
World J Methodol. 2023 Sep 20;13(4):296-322. doi: 10.5662/wjm.v13.i4.296.
3
Post-COVID-19 syndrome mimicking cholangiocarcinoma: A case report.
Clin Case Rep. 2023 May 30;11(6):e7449. doi: 10.1002/ccr3.7449. eCollection 2023 Jun.
4
COVID-Associated Cast-Forming Cholangiopathy: A Commentary on Disease Mechanism, Treatment, and Prognosis.
Hepat Med. 2023 Mar 28;15:27-32. doi: 10.2147/HMER.S384176. eCollection 2023.
5
Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imaging.
Endosc Ultrasound. 2023 Mar-Apr;12(2):181-199. doi: 10.4103/EUS-D-22-00208.
6
Post-COVID cholangiopathy: A narrative review.
Gastroenterol Hepatol. 2023 Jun-Jul;46(6):474-482. doi: 10.1016/j.gastrohep.2022.09.004. Epub 2022 Sep 27.
Zotero 插件